Tune Up Your Back: Soundwave Wellness Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: WAVWatch 2.0.
- Who it may be relevant to
- Registry conditions: Pain, Back. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Looking to support your back mobility and overall comfort? Join our study exploring WAVwatch 2.0, an innovative soundwave therapy device. This non-invasive technology is designed for individuals who want to maintain easy movement and flexibility without constantly reaching for over-the-counter options. By joining, you'll discover how this gentle approach may help support everyday back comfort, mobility, and flexibility.
Detailed description
This remotely administered decentralized trial is designed to methodically explore the efficacy of WAVwatch 2.0, a non-invasive device that leverages soundwave therapy, in enhancing back comfort and flexibility. In the wake of increasing reliance on temporary solutions for back tension and stiffness, this study emerges as a pivotal investigation into whether soundwave therapy can offer a sustainable pathway to maintaining ease of back movement and overall wellness.
The primary objective of this online trial is to facilitate participants in understanding the potential benefits of WAVwatch 2.0 on their daily comfort, range of motion, and general quality of life. Through this exploratory journey, participants will receive personalized insights, enabling a comprehensive understanding of how soundwave therapy might influence their back comfort and mobility. This initiative aims not only to assess the device's ability to support back wellness but also to empower participants with knowledge about alternative, non-invasive options for enhancing their quality of life.
Focusing on the experiential changes in ease of movement, daily activities, and overall wellness, the study intends to rigorously evaluate and document the impact of WAVwatch 2.0 on participants. By doing so, it seeks to offer a detailed perspective on the device's effectiveness in promoting back health and comfort. The trial is committed to providing participants with a clear, personalized overview of how soundwave therapy could integrate into their wellness routines, potentially redefining approaches to back care.
The significance of this remotely conducted trial extends beyond individual benefits, aiming to contribute to the broader understanding of non-invasive back care solutions. By examining the outcomes of using WAVwatch 2.0 for back comfort and mobility, the study aspires to challenge and expand current perspectives on managing back tension and stiffness, offering new insights into the role of soundwave therapy in daily wellness practices.
It is important to note that throughout this trial, the PROMISE and ROMISE scales will serve as key tools in assessing participants' quality of life, comfort, and ease of movement. These scales, while integral to evaluating the benefits of WAVwatch 2.0, are not utilized as diagnostic instruments but as means to gauge the subjective experience of participants, thereby enriching the study's findings on the feasibility of soundwave therapy as a supportive measure for back wellness.
Interventions
- Device WAVWatch 2.0
The WAVwatch sound frequency therapy device employs acoustic waves absorbed through the skin to promote wellness, with manufacturers and users reporting minimal safety risks
Primary outcome measures
- PROMIS® Item Bank/Scale v.2.0 - Pain Behavior Survey [Time frame: Change from baseline (Day 1-3) in pain behavior at 4 weeks after the start of the intervention (Day 27-33)]
- Quality of Life and Health Survey [Time frame: Change from baseline (Day 1-3) in quality of life at 4 weeks after the start of the intervention (Day 27-33)]
- ROMIS® Numeric Rating Scale v.1.0 - Pain Intensity 1a [Time frame: Change from baseline (Day 1-3) in pain intensity at 1 week after the start of the intervention (Day 4-10)]
Eligibility criteria
Inclusion criteria
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Efforia — New York
Identifiers
NCT: NCT07256626 · 37378